Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy

NCT03636958 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT03636958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03636958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Withdrawn
Start date
February 15, 2021
Completion date
December 1, 2026
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy